Your browser is no longer supported. Please, upgrade your browser.
Settings
AQXP Aquinox Pharmaceuticals, Inc. daily Stock Chart
AQXP [NASD]
Aquinox Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.80 Insider Own0.32% Shs Outstand25.34M Perf Week-7.69%
Market Cap54.73M Forward P/E- EPS next Y-0.86 Insider Trans0.00% Shs Float23.46M Perf Month-18.80%
Income-42.10M PEG- EPS next Q-0.44 Inst Own79.20% Short Float0.84% Perf Quarter-29.18%
Sales25.00M P/S2.19 EPS this Y-14.30% Inst Trans6.57% Short Ratio1.16 Perf Half Y-82.73%
Book/sh3.86 P/B0.56 EPS next Y-28.40% ROA-52.30% Target Price14.50 Perf Year-80.06%
Cash/sh4.03 P/C0.54 EPS next 5Y- ROE-58.00% 52W Range1.96 - 16.90 Perf YTD-81.63%
Dividend- P/FCF- EPS past 5Y-12.00% ROI- 52W High-87.22% Beta-
Dividend %- Quick Ratio7.70 Sales past 5Y- Gross Margin- 52W Low10.20% ATR0.14
Employees30 Current Ratio7.70 Sales Q/Q- Oper. Margin- RSI (14)27.39 Volatility7.20% 5.67%
OptionableYes Debt/Eq0.00 EPS Q/Q120.80% Profit Margin- Rel Volume1.19 Prev Close2.13
ShortableYes LT Debt/Eq0.00 EarningsNov 14 AMC Payout- Avg Volume168.73K Price2.16
Recom3.00 SMA20-13.71% SMA50-19.44% SMA200-74.35% Volume200,020 Change1.17%
Feb-09-18Initiated Guggenheim Buy $26
Dec-16-16Initiated Cantor Fitzgerald Overweight
Oct-04-16Resumed Leerink Partners Outperform $24
Mar-16-16Reiterated Leerink Partners Outperform $26 → $21
Oct-23-15Initiated Needham Buy $25
Oct-06-15Initiated Guggenheim Buy $22
Sep-11-15Reiterated Canaccord Genuity Hold $10 → $22
Jul-10-15Downgrade Jefferies Buy → Hold
Mar-17-15Reiterated Canaccord Genuity Buy $12 → $17
Oct-16-14Initiated Canaccord Genuity Buy $12
Nov-07-18 10:21AM  Aquinox: 3Q Earnings Snapshot Associated Press
09:15AM  Aquinox Pharmaceuticals Announces Third Quarter 2018 Financial Results GlobeNewswire
Nov-01-18 08:55AM  Consolidated Research: 2018 Summary Expectations for Aquinox Pharmaceuticals, Xilinx, West Pharmaceutical Services, nVent Electric, World Wrestling Entertainment, and HD Supply Fundamental Analysis, Key Performance Indications GlobeNewswire +5.04%
Aug-08-18 06:22AM  Aquinox: 2Q Earnings Snapshot Associated Press
06:15AM  Aquinox Pharmaceuticals Announces Second Quarter 2018 Financial Results GlobeNewswire
Jul-24-18 09:00AM  These Small Biotech Companies Could Bring a 300% Return Before end of the Year ACCESSWIRE
07:35AM  Complimentary Technical Snapshots on Aquinox Pharma and Three More Healthcare Stocks ACCESSWIRE
Jul-13-18 08:39AM  Akorn (AKRX) Looks Good: Stock Adds 7.8% in Session Zacks
Jul-10-18 09:23AM  Aquinox Pharmaceuticals (AQXP) Enters Oversold Territory Zacks -5.86%
08:11AM  Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna Coverage Benzinga
Jun-28-18 08:00AM  Todays Research Reports on Stocks to Watch: Aquinox Pharmaceuticals and Summit Therapeutics ACCESSWIRE
Jun-27-18 05:22PM  Why Sonic, National Beverage, and Aquinox Pharmaceuticals Slumped Today Motley Fool -84.72%
02:40PM  Aquinox Pharma Shares Plunge 85% After Failed Test Results TheStreet.com
10:42AM  Aquinox to stop development of lead drug; shares plunge Reuters
06:30AM  Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome GlobeNewswire
Jun-11-18 09:05AM  Aquinox Pharmaceuticals Announces Initiation of ProShip Phase 2 Proof-of-Concept Clinical Trial Investigating Rosiptor in CP/CPPS GlobeNewswire
May-16-18 01:32PM  Aquinox to Present at 2018 UBS Global Healthcare Conference GlobeNewswire
May-09-18 09:00PM  Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan GlobeNewswire
May-08-18 09:31AM  Aquinox: 1Q Earnings Snapshot Associated Press
09:05AM  Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results GlobeNewswire
May-07-18 12:19PM  How Do Analysts See Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) Performing Over The Next Few Years? Simply Wall St.
May-02-18 12:54PM  Aquinox to Present at Deutsche Bank 43rd Annual Healthcare Conference GlobeNewswire
Apr-26-18 09:05AM  Aquinox to Present at 2018 Bloom Burton & Co. Healthcare Conference GlobeNewswire
Mar-26-18 07:30AM  Free Research Report as Zoetis Quarterly Revenues Gained 13% and Adjusted EPS Soared 47% ACCESSWIRE
Mar-21-18 09:00AM  Aquinox to Present at the 17th Annual Needham Healthcare Conference GlobeNewswire
Mar-12-18 05:08PM  Aquinox reports 4Q loss Associated Press
04:05PM  Aquinox Pharmaceuticals Announces Year End 2017 Financial Results GlobeNewswire
01:00PM  Aquinox Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
07:36AM  Morning News Call - Canada, March 12 Reuters
Mar-05-18 09:15AM  Aquinox Pharmaceuticals to Announce Year End 2017 Financial Results GlobeNewswire
Feb-09-18 08:30AM  Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor GlobeNewswire +14.25%
Feb-02-18 06:00AM  Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference GlobeNewswire
Jan-26-18 09:05AM  Aquinox to Host Analyst and Investor Event in New York City GlobeNewswire
Dec-15-17 09:00AM  Aquinox Promotes Lloyd Mackenzie to Chief Operating Officer and Vice President, R&D Operations GlobeNewswire +10.23%
Dec-07-17 07:25PM  Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) GlobeNewswire
Nov-22-17 09:15AM  Aquinox to Participate in 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-08-17 10:15AM  Aquinox reports 3Q loss Associated Press
09:05AM  Aquinox Pharmaceuticals Announces Third Quarter 2017 Financial Results GlobeNewswire
Sep-18-17 04:15PM  Aquinox to Present at 2017 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire +7.63%
Aug-28-17 09:15AM  Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain Syndrome GlobeNewswire
Aug-08-17 10:23PM  Aquinox reports 2Q loss Associated Press
08:05AM  Aquinox Pharmaceuticals Announces Second Quarter 2017 Financial Results GlobeNewswire
05:30AM  Investor Network: Aquinox Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-17 09:15AM  Aquinox to Present at Canaccord Genuity 37th Annual Growth Conference GlobeNewswire
Aug-01-17 09:15AM  Aquinox Pharmaceuticals to Announce Second Quarter 2017 Financial Results GlobeNewswire
Jul-07-17 08:15AM  Corium International (CORI) Catches Eye: Stock Jumps 11.9% Zacks
Jun-08-17 10:05AM  Allergan to Buy Keller Funnel, Boost Plastic Surgery Unit Zacks
Jun-01-17 09:00AM  Aquinox to Present at Jefferies 2017 Global Healthcare Conference GlobeNewswire
08:25AM  Supernus Pharmaceuticals (SUPN) Jumps: Stock Rises 6.2% Zacks
May-19-17 07:00AM  6 Hot Unusual Volume Setups TheStreet.com
May-09-17 09:29AM  Aquinox reports 1Q loss Associated Press +8.37%
09:15AM  Aquinox Pharmaceuticals Announces First Quarter 2017 Financial Results GlobeNewswire
Apr-25-17 04:45PM  Aquinox to Present at 2017 Bloom Burton & Co. Healthcare Investor Conference GlobeNewswire +8.15%
Mar-29-17 04:30PM  Aquinox to Present at the 16th Annual Needham Healthcare Conference GlobeNewswire
Mar-27-17 04:05PM  Aquinox Announces Appointment of Dr. Kelvin Neu and Dr. Richard Levy to Board of Directors GlobeNewswire
04:03PM  AQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
Mar-16-17 04:41PM  AQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-15-17 01:04PM  AQUINOX PHARMACEUTICALS, INC Financials
Mar-14-17 04:30PM  Aquinox to Present at the Oppenheimer & Co. 27th Annual Healthcare Conference GlobeNewswire
Mar-09-17 04:30PM  Aquinox Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:29PM  AQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:06PM  Aquinox Pharmaceuticals Announces Year End 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 Aquinox Pharmaceuticals Inc Earnings Release - After Market Close
Mar-02-17 04:35PM  Aquinox Pharmaceuticals to Announce 2016 Year End Financial Results GlobeNewswire
Feb-28-17 08:23AM  Can Shares of Aquinox Pharmaceuticals Continue to Rocket Higher? Motley Fool
08:23AM  Can Shares of Aquinox Pharmaceuticals Continue to Rocket Higher? at Motley Fool
Feb-09-17 09:15AM  Aquinox to Present at Leerink Partners 6th Annual Global Healthcare Conference GlobeNewswire
Jan-17-17 10:50AM  Corporate Insiders at These 5 Companies Are Buying Large Sums of Stock TheStreet.com
10:50AM  Corporate Insiders at These 5 Companies Are Buying Large Sums of Stock
Jan-16-17 05:45PM  Largest Insider Trades of the Week GuruFocus.com
Jan-15-17 10:10AM  Huge Michael Dell Purchase Highlights Insider Buying: Dell Technologies, Accelerate Diagnostics, Loxo Oncology and More
Jan-10-17 09:11AM  Can The Uptrend Continue for Aquinox Pharmaceuticals (AQXP)?
Dec-18-16 10:13PM  Is Aquinox Pharmaceuticals Inc (AQXP) A Good Stock To Buy? at Insider Monkey
Dec-16-16 09:52AM  Can The Uptrend Continue for Aquinox Pharmaceuticals (AQXP)? -6.64%
08:00AM  Coverage initiated on Aquinox Pharma by Cantor Fitzgerald
Dec-15-16 10:34AM  Aquinox Pharmaceuticals, Inc. :AQXP-US: Earnings Analysis: Q3, 2016 By the Numbers : December 15, 2016 +14.79%
Dec-09-16 08:45AM  Voyager Therapeutics (VYGR) in Focus: Stock Rises 9.4%
Nov-24-16 05:48PM  The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3 at Insider Monkey
Nov-22-16 09:15AM  Aquinox and the University of Southampton Announce Presentation of Abstract at American Society of Hematology Annual Meeting GlobeNewswire
Nov-09-16 09:11AM  Aquinox reports 3Q loss +7.22%
09:06AM  AQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
09:05AM  Aquinox Pharmaceuticals Announces Third Quarter 2016 Financial Results GlobeNewswire
09:04AM  AQUINOX PHARMACEUTICALS, INC Files SEC form 10-Q, Quarterly Report
Nov-03-16 09:49AM  Endo (ENDP) Q3 Earnings: Will the Stock Pull a Surprise?
Oct-25-16 06:14AM  [$$] The Next Big Moves in Health-Care Stocks at Barrons.com
Oct-11-16 02:34PM  Aquinox Pharmaceuticals, Inc. :AQXP-US: Earnings Analysis: Q2, 2016 By the Numbers : October 11, 2016
Oct-03-16 09:15AM  Aquinox Announces Appointment of Dr. Barbara Troupin as Chief Medical Officer GlobeNewswire
Sep-27-16 06:19AM  [$$] Two Cancer Biotechs See Bullish Insider Buying at Barrons.com
Sep-25-16 10:15AM  Giant Biotech and Energy Insider Buys Highlight Wild Market Week: Chesapeake Energy, Cheniere Energy, Phillips 66 and More at 24/7 Wall St.
Sep-23-16 01:15PM  Aquinox Announces Closing of $75.4 Million Public Offering of Common Stock, Including Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Sep-20-16 05:13PM  AQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
12:20AM  Aquinox Prices Public Offering of Common Stock GlobeNewswire
Sep-19-16 04:15PM  Aquinox Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire
Sep-16-16 09:38AM  Aquinox Pharmaceuticals (AQXP) is in Overbought Territory: What's Next?
Sep-06-16 09:15AM  Aquinox Pharmaceuticals Initiates Patient Dosing in LEADERSHIP 301 Phase 3 Clinical Trial of AQX-1125 in Interstitial Cystitis/Bladder Pain Syndrome GlobeNewswire
09:11AM  AQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Aug-12-16 06:11PM  Edited Transcript of AQXP earnings conference call or presentation 4-Aug-16 8:30pm GMT
Aug-05-16 06:47AM  Aquinox reports 2Q loss
Aug-04-16 04:15PM  Aquinox Pharmaceuticals Announces Second Quarter 2016 Financial Results GlobeNewswire
04:09PM  AQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Aquinox Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in developing novel therapeutics for chronic urological conditions by inflammation and pain. The company focuses on a library of novel compounds that activate SH2-containing inositol-5'-phosphatase 1 (SHIP1) to develop therapeutics for application in inflammation, inflammatory pain, and blood cancers. Its lead product candidate is Rosiptor (Leadership 301), a small molecule activator of SHIP1 that is in Phase III clinical trials for treatment in interstitial cystitis/bladder pain syndrome. The company was formerly known as Aquinox Pharmaceuticals (USA) Inc. and changed its name to Aquinox Pharmaceuticals, Inc. in January 2014. Aquinox Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVITT DANIEL JDirectorMay 14Option Exercise10.563,90641,2473,906May 16 07:45 PM
LEVITT DANIEL JDirectorMay 14Sale12.673,90649,4890May 16 07:45 PM
MacKenzie LloydChief Operating OfficerMar 15Option Exercise10.561,30213,7491,302Mar 19 05:58 PM
MacKenzie LloydChief Operating OfficerMar 15Sale14.631,30219,0490Mar 19 05:58 PM